Comparison Overview
Lilly España

Lilly España
Avda. De la Industria, 30 , Alcobendas, 28108, ES
Last Update: 02/02/2026
Durante casi 150 años, hemos sido pioneros en descubrimientos que cambian la vida y, hoy en día, nuestros medicamentos ayudan a más de 47 millones de personas en todo el mundo. Aprovechando el poder de la biotecnología, la química y la genética, nuestros científicos es...

Sandoz
Novartis Campus, Basel, Basel-Stadt, CH, 4056
Last Update: 30/03/2026
Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continu...
Compliance Ranges Comparison

Lilly España







Sandoz






Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Lilly España in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Sandoz in 2026.
Incident History - Lilly España (X = Date, Y = Severity)
Lilly España cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Sandoz (X = Date, Y = Severity)
Sandoz cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents

Lilly España

Sandoz
FAQ
Latest Global CVEs
PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.
PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.
PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.
PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.
PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.